The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability

被引:0
|
作者
Maciej Jaśkiewicz
Adrianna Moszyńska
Jarosław Króliczewski
Aleksandra Cabaj
Sylwia Bartoszewska
Agata Charzyńska
Magda Gebert
Michał Dąbrowski
James F. Collawn
Rafal Bartoszewski
机构
[1] Medical University of Gdansk,International Research Agenda 3P
[2] Medical University of Gdansk, Medicine Laboratory
[3] Nencki Institute of Experimental Biology of the Polish Academy of Sciences,Department of Biology and Pharmaceutical Botany
[4] Medical University of Gdansk,Laboratory of Bioinformatics
[5] University of Alabama at Birmingham,Department of Inorganic Chemistry
[6] University of Wroclaw,Department of Cell, Developmental, and Integrative Biology
来源
Cellular & Molecular Biology Letters | 2022年 / 27卷
关键词
Hypoxia; Human endothelial cells; HIF-1α; HIF-2α;
D O I
暂无
中图分类号
学科分类号
摘要
The hypoxia-inducible factors (HIF) are transcription factors that activate the adaptive hypoxic response when oxygen levels are low. The HIF transcriptional program increases oxygen delivery by inducing angiogenesis and by promoting metabolic reprograming that favors glycolysis. The two major HIFs, HIF-1 and HIF-2, mediate this response during prolonged hypoxia in an overlapping and sequential fashion that is referred to as the HIF switch. Both HIF proteins consist of an unstable alpha chain and a stable beta chain. The instability of the alpha chains is mediated by prolyl hydroxylase (PHD) activity during normoxic conditions, which leads to ubiquitination and proteasomal degradation of the alpha chains. During normoxic conditions, very little HIF-1 or HIF-2 alpha–beta dimers are present because of PHD activity. During hypoxia, however, PHD activity is suppressed, and HIF dimers are stable. Here we demonstrate that HIF-1 expression is maximal after 4 h of hypoxia in primary endothelial cells and then is dramatically reduced by 8 h. In contrast, HIF-2 is maximal at 8 h and remains elevated up to 24 h. There are differences in the HIF-1 and HIF-2 transcriptional profiles, and therefore understanding how the transition between them occurs is important and not clearly understood. Here we demonstrate that the HIF-1 to HIF-2 transition during prolonged hypoxia is mediated by two mechanisms: (1) the HIF-1 driven increase in the glycolytic pathways that reactivates PHD activity and (2) the much less stable mRNA levels of HIF-1α (HIF1A) compared to HIF-2α (EPAS1) mRNA. We also demonstrate that the alpha mRNA levels directly correlate to the relative alpha protein levels, and therefore to the more stable HIF-2 expression during prolonged hypoxia.
引用
收藏
相关论文
共 50 条
  • [31] Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1α and HIF-2α in a primary neuronal model of hypoxia
    Ralph, GS
    Parham, S
    Lee, SR
    Beard, GL
    Craigon, MH
    Ward, N
    White, JR
    Barber, RD
    Rayner, W
    Kingsman, SM
    Mundy, CR
    Mazarakis, ND
    Krige, D
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (02) : 245 - 258
  • [32] HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia
    Hackenbeck, Thomas
    Knaup, Karl Xaver
    Schietke, Ruth
    Schoedel, Johannes
    Willam, Carsten
    Wu, Xiaoqing
    Warnecke, Christina
    Eckardt, Kai-Uwe
    Wiesener, Michael Sean
    CELL CYCLE, 2009, 8 (09) : 1386 - 1395
  • [33] Localization of immunoreactive HIF-1α and HIF-2α in neuroendocrine cells of both benign and malignant prostate glands
    Monsef, Nastaran
    Helczynski, Leszek
    Lundwall, Ake
    Pahlman, Sven
    Anders-Bjartell
    PROSTATE, 2007, 67 (11) : 1219 - 1229
  • [34] Hypoxia induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells
    Li, Yang
    Qiu, Xueshan
    Zhang, Siyang
    Zhang, Qingfu
    Wang, Enhua
    CANCER BIOLOGY & THERAPY, 2009, 8 (04) : 322 - 330
  • [35] Relationship between oxidative stress and HIF-1α mRNA during sustained hypoxia in humans
    Pialoux, Vincent
    Mounier, Remi
    Brown, Allison D.
    Steinback, Craig D.
    Rawling, Jean M.
    Poulin, Marc J.
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (02) : 321 - 326
  • [36] Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells
    Ahn, Yong-Tae
    Chua, Mei-Sze
    Whitlock, James P., Jr.
    Shin, Yong-Chil
    Song, Woon-Heung
    Kim, Yongkuk
    Eom, Chi-Yong
    An, Won Gun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (06) : 1627 - 1638
  • [37] Hypoxia regulates avian cardiac Arnt and HIF-1α mRNA expression
    Catron, T
    Mendiola, MA
    Smith, SM
    Born, J
    Walker, MK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (02) : 602 - 607
  • [38] Hypoxia-inducible transcription factors, HIF1A and HIF2A, increase in aging mucosal tissues
    Ebersole, Jeffrey L.
    Novak, Michael John
    Orraca, Luis
    Martinez-Gonzalez, Janis
    Kirakodu, Sreenatha
    Chen, Kuey C.
    Stromberg, Arnold
    Gonzalez, Octavio A.
    IMMUNOLOGY, 2018, 154 (03) : 452 - 464
  • [39] HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis
    Franke, Kristin
    Kalucka, Joanna
    Mamlouk, Soulafa
    Singh, Rashim Pal
    Muschter, Antje
    Weidemann, Alexander
    Iyengar, Vasuprada
    Jahn, Steffen
    Wieczorek, Kathrin
    Geiger, Kathrin
    Muders, Michael
    Sykes, Alex M.
    Poitz, David M.
    Ripich, Tatsiana
    Otto, Teresa
    Bergmann, Sybille
    Breier, Georg
    Baretton, Gustavo
    Fong, Guo-Hua
    Greaves, David R.
    Bornstein, Stefan
    Chavakis, Triantafyllos
    Fandrey, Joachim
    Gassmann, Max
    Wielockx, Ben
    BLOOD, 2013, 121 (08) : 1436 - 1445
  • [40] Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1α and HIF-2α
    Donghoon Yoon
    David V. Okhotin
    Bumjun Kim
    Yulia Okhotina
    Daniel J. Okhotin
    Galina Y. Miasnikova
    Adelina I. Sergueeva
    Lydia A. Polyakova
    Alexei Maslow
    Yonggu Lee
    Gregg L. Semenza
    Josef T. Prchal
    Victor R. Gordeuk
    Journal of Molecular Medicine, 2010, 88 : 523 - 530